ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2022 American Transplant Congress

    Processing Personal Activity Tracker (PAT) Through Artificial Intelligence (AI) is a Promising Method to Identify Patterns of Physical Activity in Liver Transplant (LT) Candidates

    A. Duarte-Rojo1, P. M. Bloomer1, J. M. Jakicic2, E. Sejdic3

    1University of Pittsburgh Medical Center, Pittsburgh, PA, 2Adventa Health, Orlando, FL, 3University of Pittsburgh, Pittsburgh, PA

    *Purpose: Prehabilitation is recommended for frail and pre-frail LT candidates. Although home-based programs are generalizable, their success depends on the adherence to an exercise prescription.…
  • 2022 American Transplant Congress

    Evs from Patients with Amr Induce Tubular Senescence and Endmt Through Horizontal Transfer of Mirnas

    R. Franzin1, A. Stasi1, F. Sallustio1, S. Bruno2, G. Merlotti3, M. Quaglia3, G. Grandaliano4, P. Pontrelli1, J. Thurman5, G. Camussi2, G. Stallone6, V. Cantaluppi3, L. Gesualdo1, G. Castellano7

    1DETO, University of Bari, Bari, Italy, 2University of Turin, Turin, Italy, 3University of Piemonte Orientale, Novara, Italy, 4Università Cattolica Sacro Cuore, Rome, Italy, 5University of Colorado School of Medicine, Aurora, CO, 6University of Foggia, Foggia, Italy, 7University of Milan, Milan, Italy

    *Purpose: Extracellular vesicles (EV) are emerging mediators in several diseases; however, their role in antibody-mediated allograft rejection (AMR) has been poorly investigated.*Methods: Plasma EVs from…
  • 2022 American Transplant Congress

    Influence of Regulatory B Cells on B Cells

    Q. Fu1, K. M. Lee2, K. Deng2, D. Agarwal1, R. Matheson3, T. Press1, J. Lei4, H. Yang5, C. LeGuern2, S. Deng5, J. F. Markmann2

    1Center for Transplant Science, MGH, Boston, MA, 2Massachusetts General Hospital, Boston, MA, 3Transplantation Surgery Research, Massachusetts General Hospital, Boston, MA, 4Surgery, Mass General, Boston, MA, 5Sichuan Provincial People's Hospital, University of Electronic Sciences and Technology of China, Chengdu, China

    *Purpose: Our previous study showed that Bregs-TLR, one type of previously studied Breg expanded in vitro, are capable of suppressing naïve B cell proliferation in…
  • 2022 American Transplant Congress

    The Impact of Long-Term Exposure to Tacrolimus on Chronic Kidney Disease Following Lung Transplantation: A Retrospective Analysis from a Single Transplantation Center

    D. Xiong, J. Zhang, J. Chen

    Lung Transplantation Center, Department of Thoracic Surgery, Wuxi People’s Hospital Affiliated to Nanjing Medical Univer, Wuxi, China

    *Purpose: Chronic kidney disease (CKD) is a progressive and irreversible complication in lung transplant patients who have received long-term treatment with tacrolimus. This study aimed…
  • 2022 American Transplant Congress

    Reduced CD45RA-CCR7- Tregs Subtypes in Highly Sensitised Patients Associates with a Failure to Regulate Memory IFNγ Production in Response to Donor Alloantigens

    C. Dudreuilh1, S. Basu1, O. Shaw2, H. Burton1, C. Domingo-Vila1, T. Tree1, G. Lombardi1, C. Scotta1, A. Dorling1

    1King's College London, London, United Kingdom, 2Viapath Clinical Transplantation Laboratory, Guy's Hospital, London, United Kingdom

    *Purpose: Highly sensitised (HS) patients exhibit worse long-term outcomes after kidney transplantation compared to non-sensitised patients. It has been hypothesised that regulatory T cells (Tregs)…
  • 2022 American Transplant Congress

    First-in-human Study Of Lis1, A Novel Glyco-humanized Anti-lymphocyte Swine Polyclonal Antibody, In Kidney Transplantation: Safety And Efficacy

    J. Slatinska1, B. Vanhove2, M. Kolarova1, F. Shneiker2, J. Rousse2, C. Galli3, J. Bach4, E. Cozzi5, J. Soulillou6, O. Duvaux2, O. Viklicky1

    1Institute for Clinical and Experimental Medicine, Prague, Czech Republic, 2Xenothera, Nantes, France, 3Laboratorio di Tecnologie della Riproduzione, Cremone, Italy, 4IECM, Immunoendocrinology, USC1383, Oniris, INRAE, Nantes, France, 5Transplantation Immunology Unit, Padua University Hospital, Padova, Italy, 6Nantes Universités, Nantes, France

    *Purpose: to assess safety, T cell depletion, PK/PD and determine the therapeutic dose of LIS1, a purified anti-lymphocyte glyco-humanized polyclonal swine IgG, derived by immunizing…
  • 2022 American Transplant Congress

    Outcomes of Primary Simultaneous Pancreas-Kidney Transplants by Induction Agent in the United States

    A. Cerise1, T. Shaker1, K. Ramanathan1, S. Jackson2, R. Kandaswamy1, S. Riad3

    1Surgery, University of Minnesota, Minneapolis, MN, 2Analytics, MHealth-Fairview, Minneapolis, MN, 3Medicine, University of Minnesota, Minneapolis, MN

    *Purpose: Induction immunosuppression choice for simultaneous pancreas-kidney (SPK) transplants varies widely in the United States. We examined the association between induction agents and outcomes of…
  • 2022 American Transplant Congress

    Impact of Changing Tacrolimus Formulation on Cerebral Blood Flow and Cognitive Function

    I. Mahaparn, R. Lepping, R. N. Montgomery, R. Mukherjee, S. Billinger, W. M. Brooks, A. Gupta

    University of Kansas Medical Center (KUMC), Kansas City, KS

    *Purpose: To assess if switching to extended release (ER) tacrolimus changes cerebral blood flow (CBF) or cognitive function after switching stable kidney transplant (KT) recipients…
  • 2022 American Transplant Congress

    Off-the-Shelf Allogeneic Invariant NKT Cells Are Safe in the Dog and Induce Both Killer and Regulatory Immune Cells

    A. Rotolo, E. Whelan, M. Atherton, K. Coker, R. Duran-Struuck, N. Mason

    University of Pennsylvania Veterinary School of Medicine, Philadelphia, PA

    *Purpose: Allogeneic invariant Natural Killer T cells (allo-iNKT) are attractive for transplant as they prevent graft rejection and maintain anti-tumor/pathogen effects but do not induce…
  • 2022 American Transplant Congress

    Alloimmune Recognition Blocks Recipient Macrophage Differentiation into Reparative Subsets

    J. Warunek1, A. Lucas2, L. R. Mathews2, M. Oberbarnscheidt2, F. Lakkis2, H. Turnquist2

    1Immunology, Thomas E. Starzl Transplantation Institute, University at Pittsburgh, Pittsburgh, PA, 2Surgery, Thomas E. Starzl Transplantation Institute, Pittsburgh, PA

    *Purpose: Monocytes differentiate into macrophage subsets that orchestrate tissue repair in response to damage signals and local cytokines. After heart transplant (Tx), graft IL-33 acts…
  • « Previous Page
  • 1
  • …
  • 158
  • 159
  • 160
  • 161
  • 162
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences